AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.
External link for AstriVax
Ambachtenlaan 1
Heverlee, Flemish Region 3001, BE
About last night …. opening of AstriVax new labs and office! #celebratingkeymoments #brightkeynotespeaker Johan Neyts #goodfood #passionatepeople #greatfun #officialmoment ✂ Shelley Margetson and Caroline Goddeeris #gratefulforthesupport! Pictures by Goele Bosmans
Excited to announce that our company moves into clinical phase with our cutting-edge technology! The first participants have been dosed in ‘SAFYR’, a Phase I clinical study to test the safety and efficacy of AstriVax's technology in close to a 100 healthy adults. The first-in-human safety and immunogenicity data generated by this study will be a stepping stone in advancing AstriVax immunotherapies to treat chronic Hepatitis B and human papillomavirus (HPV) infections. #clinical stage #team #biotech #vaccines #infectious diseases #immunotherapies https://lnkd.in/d5ADh5R6
We’re releasing promising preclinical efficacy data with our #hepatitisB therapeutic vaccine at #EASLCongress 2024 (June 5-8). Join our CEO Hanne Callewaert, CBO Gregory Fanning, CDO Mathieu Peeters, vaccine development leader Frederik Pauwels or senior scientist Goele Bosmans in Milan to hear more about AstriVax mission to contribute to the treatment of millions of people chronically infected with hepatitis B. #hepatitisb #treatment #therapeutics #vaccines #biotech #data
------------------- Hiring alert ---------------------- We are looking for a lab technician with a passion for hands-on lab work in the immunology field and a strong affinity for in vivo activities. Interested? Send you CV to hr@astrivax.com directly (no recruiters). https://lnkd.in/eTmU-E6N
Our team very often does the extra mile at AstriVax to advance our vaccines through development! They don't only do extra miles at work, but also in sports! 💥 Yesterday, they completed the 10 miles in Antwerp! 💥 In March, they ran the 100km to beat cancer! Congrats to all the runners! 💪
Our CEO Hanne Callewaert will present the latest AstriVax updates at the 'Infectious Diseases R&D Spotlight Session' at Biotrinity in London on April 23, 2024. Join us to hear more about our vaccine technology and indications!
We're pleased to welcome to Dr. Gregory Fanning as Chief Business Officer at AstriVax! Greg brings over 20 years of experience as a scientific leader in the pharma industry and has supported small biotech companies in creating infectious disease pipelines by internal R&D and licensing. Greg has been advisor to AstriVax and will join the leadership team in the role of CBO. Welcome Gregory Fanning! #team #leadership #vaccines #therapeutics #businessdevelopment
Passionate about molecular biology and excited to work in a lab? You may be the colleague we're looking for at AstriVax! Please apply directly to hr@astrivax.com. https://lnkd.in/e6zPEYuZ #hiring #molecularbiology #vaccines #laboratory #labtechnician
AstriVax is hiring a clinical development lead! Are you an MD with experience in clinical research and passionate by vaccines or infectious disease science? Apply at hr@astrivax.com to join us in our exciting journey to bring our vaccines closer to the patients! https://lnkd.in/eXd6dDij #hiring #vaccines #clinicaltrials #clinicalresearch #clinicaldevelopment